(Q35592385)

9 August 2017

1 reference

title

Azelnidipine. (English)

1 reference

9 August 2017

2

Lesley J Scott

1 reference

9 August 2017

Keri Wellington

1

1 reference

9 August 2017

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

63

1 reference

9 August 2017

23

1 reference

9 August 2017

2613-21; discussion 2623-4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363230-00004

9 August 2017

0 references

cites work

Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR

1 reference

12 December 2020

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

1 reference

12 December 2020

Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure

1 reference

12 December 2020

Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Effects of dihydropyridine Ca blockers on the renal function in nephrotic spontaneously hypertensive rat (SHR)

1 reference

12 December 2020

Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR

1 reference

12 December 2020

Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs.

1 reference

12 December 2020

Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation

1 reference

12 December 2020

A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.

1 reference

12 December 2020

10.2165/00003495-200363230-00004

Identifiers

DOI

1 reference

PubMed ID

14636080

Dimensions Publication ID

9 August 2017

0 references

1 reference

PubMed ID

14636080